Loading clinical trials...

Genetic Determinants of Kawasaki Disease | Clinical Trials | Clareo Health

UNKNOWNNCT03861130

Genetic Determinants of Kawasaki Disease

Kawasaki disease (KD) is an acute self-limited vasculitis of infancy and early childhood. Most patients recover without sequelae although the inflammatory process causes permanent damage to the corona...

Lead sponsor: Imperial College London•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGNA

Kawasaki MATCH Trial

NCT07291245 · Kawasaki Disease

RECRUITINGPhase 4

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

NCT05643651 · Kawasaki Disease, Coronary Artery Aneurysm

RECRUITING

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

NCT06993636 · Kawasaki Disease, Coronary Artery Aneurysm, and more

RECRUITINGPhase 3

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment

NCT04656184 · Kawasaki Disease

Active Not RecruitingPhase 2

Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

NCT01917721 · Kawasaki Disease, Coronary Aneurysm

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,379

Start dateFeb 2013

Last updatedNov 17, 2022

Condition

Kawasaki Disease Atypical Kawasaki Disease

Locations shown

Imperial College London

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions